OBJECTIVE	Teduglutide , a GLP-2 analogue , may restore intestinal structural and functional integrity by promoting repair and growth of the mucosa and reducing gastric emptying and secretion , thereby increasing fluid and nutrient absorption in patients with short bowel syndrome ( SBS ) .\